| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K66453893 |
| PharmacoGx | BRD-K66453893 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIF15 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | INTU | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | CASKIN1 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | CYB5RL | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | INTS9 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | UBE2O | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | CD59 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | HNRNPD | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | TRIOBP | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | HNRNPU | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
